223 related articles for article (PubMed ID: 6136102)
1. [The use of histamine H2 receptor blockaders in gastroenterology].
Waldum HL; Petersen H
Tidsskr Nor Laegeforen; 1983 Apr; 103(12):980-3. PubMed ID: 6136102
[No Abstract] [Full Text] [Related]
2. [A new H2-receptor antagonist in the treatment of gastrointestinal diseases].
Senfft U
Med Welt; 1982 Oct; 33(43):1516-8. PubMed ID: 6130463
[No Abstract] [Full Text] [Related]
3. [Histamine H2 receptor antagonists and upper digestive hemorrhage].
Blanchi A; Soulé JC
Gastroenterol Clin Biol; 1985 Feb; 9(2):153-61. PubMed ID: 2858426
[No Abstract] [Full Text] [Related]
4. The use and abuse of histamine H2-receptor antagonists.
Milton-Thompson GJ
J R Nav Med Serv; 1977; 63(1):9-14. PubMed ID: 17005
[No Abstract] [Full Text] [Related]
5. [Cimetidine: a review (author's transl)].
Hoffenberg P
Rev Med Chil; 1979 Mar; 107(3):245-50. PubMed ID: 38497
[No Abstract] [Full Text] [Related]
6. [Cimetidine and recent H2-receptor blocking agents in the therapy of gastrointestinal diseases].
Gugler R; Musch E
Med Welt; 1982 Aug; 33(31-32):1083-86. PubMed ID: 6127590
[No Abstract] [Full Text] [Related]
7. H2-receptor antagonists.
Nurs Times; 2004 Nov 2-8; 100(44):33. PubMed ID: 15552489
[No Abstract] [Full Text] [Related]
8. Gastric acid suppressants--too much of a good thing?
Logan IC; Sumukadas D; Witham MD
Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
[No Abstract] [Full Text] [Related]
9. Overview of 50 years' progress in upper gastrointestinal diseases.
Yeomans ND
J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S2-4. PubMed ID: 19799693
[TBL] [Abstract][Full Text] [Related]
10. [Clinical importance of antagonists of histamine H2 receptors in gastroenterology].
Carella G
Clin Ter; 1984 Mar; 108(6):525-9. PubMed ID: 6144411
[No Abstract] [Full Text] [Related]
11. [Antacids and muscarinic and histamine H2 receptor blockaders in the treatment of peptic ulcer].
Ivashkin VT; Minasian GA
Klin Med (Mosk); 1987 Jan; 65(1):24-31. PubMed ID: 2882061
[No Abstract] [Full Text] [Related]
12. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage I-II preparations in the therapy of internal diseases].
Grebnev AL; Miagkova LP; Kkhorshed AM
Klin Med (Mosk); 1991 Mar; 69(3):23-7. PubMed ID: 1676772
[No Abstract] [Full Text] [Related]
13. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
Bardhan KD
Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
[TBL] [Abstract][Full Text] [Related]
14. [Clinical aspects of Kvamatel (famotidine) administration].
Golochevskaia VS
Klin Med (Mosk); 1996; 74(1):45-7. PubMed ID: 8649009
[No Abstract] [Full Text] [Related]
15. [Guidelines for good practice: anti-ulcer agents, indications in the adult. French Agency for Health Safety of Health Products].
Therapie; 1999; 54(5):509-17. PubMed ID: 10667082
[No Abstract] [Full Text] [Related]
16. [25 years of gastric acid blockers].
Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
[TBL] [Abstract][Full Text] [Related]
17. [H2 receptor blockaders: domains for oral use. Indications for cimetidine and ranitidine in gastroenterology].
Hotz J
Fortschr Med; 1984 Feb; 102(8):203-4. PubMed ID: 6086477
[No Abstract] [Full Text] [Related]
18. Drug therapy of peptic ulcer disease.
Ching CK; Lam SK
Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
[TBL] [Abstract][Full Text] [Related]
19. Ebrotidine--a nostrum for ulcer.
Grover JK; Rathi SS; Vats V
Trop Gastroenterol; 1997; 18(3):111-3. PubMed ID: 9385853
[No Abstract] [Full Text] [Related]
20. Approach to the patient with unexplained chest pain.
Katz PO; Codario R; Castell DO
Compr Ther; 1997 Apr; 23(4):249-53. PubMed ID: 9167916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
